Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2014. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
FDA Considering OTC Use of Singulair for Allergies
WEDNESDAY, April 30, 2014 (HealthDay News) -- Over-the-counter use of Singulair as a treatment for allergies is being considered by the U.S. Food and Drug Administration.
Health Highlights: April 30, 2014
Limited Associations for Antiretroviral Tx, Birth Defects
WEDNESDAY, April 30, 2014 (HealthDay News) -- There is a specific association between in utero exposure to zidovudine and heart defects; however, most ART drugs are not linked to birth defects, according to a study published online April 29 in PLOS Medicine.
Full Text
Editorial
Modafinil Doesn't Improve NSCLC-Related Fatigue
WEDNESDAY, April 30, 2014 (HealthDay News) -- The central nervous system stimulant modafinil is not effective in treating non-small-cell lung cancer-related fatigue, according to a study published online April 28 in the Journal of Clinical Oncology.
Abstract
Full Text
Nongroup Insurance Market Lacked Stability Before ACA
WEDNESDAY, April 30, 2014 (HealthDay News) -- The nongroup insurance market has been characterized by frequent disruptions in coverage before implementation of the Affordable Care Act (ACA), according to research published online April 23 in Health Affairs.
Abstract
Full Text
Pharmacist Service Can Be Considered 'Incident to' Service
TUESDAY, April 29, 2014 (HealthDay News) -- Physicians may bill for pharmacist services as part of the "incident to" services provided to Medicare patients, according to communication between the American Academy of Family Physicians (AAFP) and the Centers for Medicare & Medicaid Services (CMS).
More Information
High-Dose Antidepressants Tied to Increased Self-Harm
TUESDAY, April 29, 2014 (HealthDay News) -- Children and young adults taking high-dose antidepressants are at heightened risk of deliberate self-harm, compared to those taking modal-therapeutic doses, according to a study published online April 28 in JAMA Internal Medicine.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Aspirin Use Cuts CRC Risk With High 15-PGDH Expression
TUESDAY, April 29, 2014 (HealthDay News) -- Regular aspirin use is associated with a reduced risk of colorectal cancer in association with high hydroxyprostaglandin dehydrogenase 15-(nicotinamide adenine dinucleotide) (15-PGDH) expression, according to a study published in the April 23 issue of Science Translational Medicine.
Abstract
Full Text (subscription or payment may be required)
Winter's Polar Vortex Ushers in Spring's 'Pollen Vortex'
TUESDAY, April 29, 2014 (HealthDay News) -- Allergy experts say that the long, cold winter kept trees dormant for longer than usual, which means tree pollen season will overlap with grass pollen and mold seasons this year.
Full Article
Medical Marijuana May Aid Some MS Symptoms
TUESDAY, April 29, 2014 (HealthDay News) -- Certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but there is not enough evidence to support its utility in treating motor problems associated with other conditions, according to a review published in the April 29 issue of Neurology.
Abstract
Full Text
Meta-Analysis: Vitamin D Does Not Cut Falls by ≥15 Percent
TUESDAY, April 29, 2014 (HealthDay News) -- Vitamin D supplementation, with or without calcium, does not reduce the risk of falls by 15 percent or more, according to a trial sequential meta-analysis published online April 24 in The Lancet Diabetes & Endocrinology.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
FDA: Psychiatric Side Effects of Chantix to Be Reviewed in Fall
MONDAY, April 28, 2014 (HealthDay News) -- The mental health risks associated with Chantix will be reviewed at a public meeting scheduled for October, the U.S. Food and Drug Administration says. The meeting will feature a panel of experts who will discuss the psychiatric and behavioral side effects of Chantix and how best to manage them, The New York Times reported.
Health Highlights: April 28, 2014
For Statin Users, Caloric, Fat Intake Up Since 1999 to 2000
FRIDAY, April 25, 2014 (HealthDay News) -- For statin users, but not nonusers, caloric and fat intake increased significantly from 1999-2000 to 2009-2010, according to a study published online April 24 in JAMA Internal Medicine.
Abstract
Full Text
Editorial
Benzodiazepines May Worsen Respiratory Outcomes in COPD
FRIDAY, April 25, 2014 (HealthDay News) -- New use of benzodiazepines may increase the risk of adverse respiratory outcomes in older adults with chronic obstructive pulmonary disease (COPD), according to research published online April 17 in the European Respiratory Journal.
Abstract
Full Text (subscription or payment may be required)
One in 13 U.S. Schoolkids Take Psych Meds
FRIDAY, April 25, 2014 (HealthDay News) -- More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, and more than half of the parents said the drugs are helping their children, according to an April data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.
Full Article
More Information
CDC: Measles on Upswing Despite Vaccines' Effectiveness
FRIDAY, April 25, 2014 (HealthDay News) -- Vaccinations have prevented an estimated 732,000 deaths, 21 million hospitalizations, and 322 million illnesses among U.S. children born in the last 20 years, according to a government report published in the April 25 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Full Article
More Information
FDA Approves Sylvant for Multicentric Castleman's Disease
THURSDAY, April 24, 2014 (HealthDay News) -- The U.S. Food and Drug Administration has approved Sylvant (siltuximab) to treat patients with multicentric Castleman's disease (MCD), according to a news release issued by the agency today.
More Information
Physician Groups Find Fault With Medicare Payment Data Release
THURSDAY, April 24, 2014 (HealthDay News) -- Physician groups cite major problems associated with the release of Medicare payment data, according to an article published April 16 in Medical Economics.
More Information
Out-of-Pocket Costs Decline for Patients With Diabetes
THURSDAY, April 24, 2014 (HealthDay News) -- During the past decade, out-of-pocket (OOP) costs have declined for individuals with diabetes, according to research published online March 25 in Diabetes Care.
Abstract
Full Text (subscription or payment may be required)
Educational Changes Suggested for Patient-Centered Medicine
THURSDAY, April 24, 2014 (HealthDay News) -- Changes in medical education and training are suggested to help new physicians address the needs of patients and their families, according to an ideas and opinions piece published in the April 22 issue of the Annals of Internal Medicine.
Full Text (subscription or payment may be required)
Statins May Reduce Risk of Progression of Renal Cancer
WEDNESDAY, April 23, 2014 (HealthDay News) -- Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research published in the April issue of The Journal of Urology.
Abstract
Full Text
FDA Proposes Accelerated Medical Device Approval Plan
WEDNESDAY, April 23, 2014 (HealthDay News) -- The U.S. Food and Drug Administration has proposed a new program that would provide expedited access to high-risk medical devices intended for patients with serious conditions whose medical needs are not met by current technology.
More Information
FDA Approves Cyramza for Gastric Cancer
TUESDAY, April 22, 2014 (HealthDay News) -- Cyramza (ramucirumab) has been approved by the U.S. Food and Drug Administration to treat cancer of the stomach or gastroesophageal junction adenocarcinoma.
More Information
Majority of Americans Support ACA Birth Control Mandate
TUESDAY, April 22, 2014 (HealthDay News) -- Nearly 70 percent of Americans support the new health care law's mandated coverage of birth control, according to research published online April 22 in the Journal of the American Medical Association.
Full Article
Abstract
Full Text
Lorazepam No Better Than Diazepam for Epilepsy in Kids
TUESDAY, April 22, 2014 (HealthDay News) -- Lorazepam should not be preferentially used over diazepam in pediatric patients with convulsive status epilepticus, according to a study published in the April 23/30 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Some Docs Still Prescribe Codeine for Peds Cough/URI
TUESDAY, April 22, 2014 (HealthDay News) -- Despite national guidelines recommending against its use in children, some physicians continue to prescribe codeine for pediatric cough or upper respiratory infection (URI), according to research published online April 21 in Pediatrics.
Abstract
Full Text
Editorial (subscription or payment may be required)
New Muscular Dystrophy Drug's Chances for Approval Improve
MONDAY, April 21, 2014 (HealthDay News) -- A new drug to treat Duchenne muscular dystrophy may be closer to becoming the first approved treatment for the disease.
Health Highlights: April 21, 2014
Task Force Recommends Ways to Improve Price Transparency
MONDAY, April 21, 2014 (HealthDay News) -- Price transparency frameworks, which provide price information presented in the context of other relevant information, should be developed to meet patients' needs, according to recommendations presented in a report from the Healthcare Financial Management Association (HFMA).
More Information
Sprifermin May Aid Cartilage Thickness Loss With Arthritis
MONDAY, April 21, 2014 (HealthDay News) -- Sprifermin (recombinant human fibroblast growth factor 18) does not significantly reduce central medial femorotibial compartment (cMFTC) cartilage thickness, but does benefit cartilage loss in the lateral femorotibial compartment, according to a proof-of-concept study published online April 16 in Arthritis & Rheumatology.
Abstract
Full Text (subscription or payment may be required)
Antibiotics Improve Children's Growth in Poorer Nations
MONDAY, April 21, 2014 (HealthDay News) -- In low and middle income countries, antibiotics have a growth promoting effect in prepubertal children, according to research published online April 15 in BMJ.
Full Text
Editorial
FDA Approves Ragwitek for Adult Ragweed Allergy
FRIDAY, April 18, 2014 (HealthDay News) -- Ragwitek has been approved by the U.S. Food and Drug Administration to treat allergy to short ragweed among adults aged 18 to 65.
More Information
AMA Examines Economic Impact of Physicians
FRIDAY, April 18, 2014 (HealthDay News) -- Physicians who mainly engage in patient care contribute a total of $1.6 trillion in economic output, according to the American Medical Association (AMA)'s Economic Impact Study.
More Information
Free Drug Samples Tied to More Branded Prescriptions
FRIDAY, April 18, 2014 (HealthDay News) -- Free drug samples drive the prescribing practices of physicians away from less expensive generic medications, according to a study published online April 16 in JAMA Dermatology.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Trust in Provider Improves Antidepressant Adherence in DM
FRIDAY, April 18, 2014 (HealthDay News) -- Patients with diabetes who lack trust and shared decision-making with their providers are less likely to be adherent to antidepressant therapy for depression, according to research published online April 5 in the Journal of General Internal Medicine.
Abstract
Full Text (subscription or payment may be required)
White House: 8 Million People Signed Up for Health Insurance
FRIDAY, April 18, 2014 (HealthDay News) -- Eight million Americans signed up for private health insurance during the just-concluded first enrollment period under the Affordable Care Act, the White House announced Thursday afternoon.
Full Article
More Information
Experimental Measles Drug Shows Promise in Animal Trials
THURSDAY, April 17, 2014 (HealthDay News) -- Scientists have successfully tested in animals a new drug that might one day protect people infected with measles from becoming ill, according to research published in the April 16 issue of Science Translational Medicine.
Full Article
Abstract
Full Text (subscription or payment may be required)
Cancer 'Vaccine' for Advanced Disease Passes Early Hurdle
THURSDAY, April 17, 2014 (HealthDay News) -- Early progress has been made in developing a treatment that might one day help the immune system defend itself against cancer, according to research published in the April 16 issue of Science Translational Medicine.
Full Article
Abstract
Full Text (subscription or payment may be required)
CDC: Regional Trends Seen for Complementary Health Services
WEDNESDAY, April 16, 2014 (HealthDay News) -- Yoga and meditation are popular on the West Coast, Midwesterners often turn to chiropractors or osteopathic doctors, and nearly one in every five Americans use herbal supplements. These are among the findings of a new federal government report published in the U.S. Centers for Disease Control and Prevention's April edition of the National Center for Health Statistics Data Brief.
Full Article
More Information
Informed Patients Question Unnecessary Prescriptions
WEDNESDAY, April 16, 2014 (HealthDay News) -- Well-informed patients might make better choices about what prescriptions they take, according to the evaluation of an educational intervention aimed at encouraging seniors to discontinue sleeping pill use published online April 14 in JAMA Internal Medicine.
Abstract
Full Text (subscription or payment may be required)
Evidence Lacking for Long-Term Opioid Use in Low Back Pain
WEDNESDAY, April 16, 2014 (HealthDay News) -- There is evidence of short-term efficacy (moderate for pain and small for function) of opioids for treatment of chronic low back pain (CLBP) compared with placebo; however, the effectiveness and safety of long-term opioid therapy for treatment of CLBP remains unproven, according to a review published in the April 1 issue of Spine.
Full Text
Continued Reliance on Windows XP May Threaten Data Security
WEDNESDAY, April 16, 2014 (HealthDay News) -- Physicians who use Windows XP in their practices may be affected by Microsoft's recent discontinuation of support for the program, according to an article published April 8 in Medical Economics.
More Information
Extensive Atypical Antipsychotic Use in Medicaid-Insured Youth
WEDNESDAY, April 16, 2014 (HealthDay News) -- Medicaid-insured youth, particularly those in foster care and those diagnosed with attention-deficit/hyperactivity disorder (ADHD), have considerable exposure to atypical antipsychotics, according to a study published in the April issue of the Journal of Child and Adolescent Psychopharmacology.
Abstract
Full Text
FDA Approves Tanzeum for Type 2 Diabetes
TUESDAY, April 15, 2014 (HealthDay News) -- Tanzeum (albiglutide) has been approved by the U.S. Food and Drug Administration to help control blood glucose, along with diet and exercise, in adults with type 2 diabetes.
More Information
Patients Paying Much More for Specialty Drugs
TUESDAY, April 15, 2014 (HealthDay News) -- Many Americans are paying less for prescription drugs, but some are having to deal with sharp rises in the cost of specialty medicines for rare or serious diseases, according to a new report.
Health Highlights: April 15, 2014
Tripterygium Wilfordii Hook F Found Effective in Active RA
TUESDAY, April 15, 2014 (HealthDay News) -- Herbal Tripterygium wilfordii Hook F (TwHF) is effective for the treatment of active rheumatoid arthritis (RA) in disease-modifying antirheumatic drug-naive patients, according to a study published online April 14 in the Annals of the Rheumatic Diseases.
Abstract
Full Text (subscription or payment may be required)
NSAIDs With Anticoagulant Tx Ups Major Bleeding in VTE
TUESDAY, April 15, 2014 (HealthDay News) -- Concomitant use of a nonsteroidal anti-inflammatory drug (NSAID) or aspirin in patients with venous thromboembolism receiving anticoagulant therapy is tied to increased risk of bleeding, according to a study published online April 14 in JAMA Internal Medicine.
Abstract
Full Text (subscription or payment may be required)
Intensive Insulin Rx Lowers Glycemic Variability in Early DM
TUESDAY, April 15, 2014 (HealthDay News) -- Short-term intensive insulin therapy (IIT) can improve β-cell function in type 2 diabetes mellitus (T2DM) in association with decreased glycemic variability, according to a study published in the April issue of Diabetes Care.
Abstract
Full Text (subscription or payment may be required)
iPLEDGE Isotretinoin Counseling May Need Updating
MONDAY, April 14, 2014 (HealthDay News) -- The iPLEDGE program needs to provide women with information about more contraceptive choices, including reversible contraceptives, according to research published in the April issue of JAMA Dermatology.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Prenatal SSRI Exposure May Up Odds of Autism in Boys
MONDAY, April 14, 2014 (HealthDay News) -- For boys, prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) is associated with increased likelihood of autism spectrum disorder (ASD) and other developmental delays (DDs), according to a study published online April 14 in Pediatrics.
Abstract
Full Text (subscription or payment may be required)
New Health Secretary to Confront Health Care Reform Hurdles
MONDAY, April 14, 2014 (HealthDay News) -- With the resignation of U.S. Health and Human Services Secretary Kathleen Sebelius on Friday, the Affordable Care Act will get a fresh face. But turning around public perception of the controversial health care reform law in a politically charged mid-term election year poses an enormous challenge for the department's next leader, policy experts said.
Full Article
AAFP Provides Tips to Address Patients' Vaccine Concerns
MONDAY, April 14, 2014 (HealthDay News) -- Physicians remain the biggest influence on whether patients get vaccinated, and must be prepared to address patients' reservations, according to an article published in the March/April issue of Family Practice Management.
Full Text (subscription or payment may be required)
Sebelius Stepping Down As HHS Secretary
FRIDAY, April 11, 2014 (HealthDay News) -- U.S. Health and Human Services Secretary Kathleen Sebelius is stepping down from her position, after overseeing the troubled rollout of the Affordable Care Act that remains unpopular with some Americans and virtually all Republican lawmakers.
Full Article
Blood Glucose Levels Set for Achieving HbA1c Targets
FRIDAY, April 11, 2014 (HealthDay News) -- The average self-monitored blood glucose (SMBG) concentrations needed at premeal, postmeal, and bedtime have been established to achieve a range of hemoglobin A1c (HbA1c) targets, according to research published in the April issue of Diabetes Care.
Abstract
Full Text (subscription or payment may be required)
Benefits/Risks for Fibrinolytic Therapy in Intermediate-Risk PE
FRIDAY, April 11, 2014 (HealthDay News) -- A single intravenous bolus of tenecteplase reduces early death and hemodynamic decompensation in normotensive patients with intermediate-risk pulmonary embolism, but increases the risk of major hemorrhage and stroke, according to a study published in the April 10 issue of the New England Journal of Medicine.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Updated Reviews Issued for Oseltamivir, Zanamivir Use in Flu
THURSDAY, April 10, 2014 (HealthDay News) -- Oseltamivir and zanamivir reduce the time to symptomatic improvement in influenza by about half a day, but evidence to support claims of reduced admissions to hospital or complications of influenza is lacking, according to two systematic reviews of regulatory information published online April 10 in BMJ.
Full Text - Jefferson
Full Text - Heneghan
Editorial 1
Editorial 2
NSAID Use Linked to Increased Risk of Atrial Fibrillation
THURSDAY, April 10, 2014 (HealthDay News) -- In elderly adults, current and recent non-steroidal anti-inflammatory drug (NSAID) use is associated with increased risk of atrial fibrillation, according to a study published online April 8 in BMJ Open.
Abstract
Full Text
Financial Incentives Improve Completion of HBV Vaccination
THURSDAY, April 10, 2014 (HealthDay News) -- Modest financial incentives significantly improve adherence to hepatitis B virus (HBV) vaccination programs among patients receiving opioid dependence treatment, according to a study published online April 9 in The Lancet.
Abstract
Full Text
Editorial
Fewer Americans Overwhelmed by Medical Bills
WEDNESDAY, April 9, 2014 (HealthDay News) -- While millions of Americans still feel hamstrung by medical expenses, a new government report shows that some people are getting relief.
Full Article
More Information
Spironolactone Doesn't Improve Set of Outcomes in Diastolic CHF
WEDNESDAY, April 9, 2014 (HealthDay News) -- Spironolactone did not significantly reduce a composite outcome end point in heart failure patients with a preserved ejection fraction, according to a study published in the April 10 issue of the New England Journal of Medicine.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Some Doctors Paid at Least $3 Million Each by Medicare
WEDNESDAY, April 9, 2014 (HealthDay News) -- A small number of doctors received at least $3 million each in Medicare payments in 2012, for a total of nearly $1.5 billion, according to an analysis of Medicare claims data released Wednesday by the White House. In total, Medicare paid individual physicians nearly $64 billion in 2012. The median payment was just over $30,000, the Associated Press reported.
Health Highlights: April 9, 2014
More Information
Conventional Chemo May Be Better for Some Advanced NSCLC
TUESDAY, April 8, 2014 (HealthDay News) -- For patients with non-small-cell lung cancer (NSCLC) and wild-type (WT) epidermal growth factor receptor (EGFR) mutations, conventional chemotherapy improves progression-free survival (PFS) better than first-generation EGFR tyrosine kinase inhibitors (TKIs), according to research published in the April 9 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
NCQA Updates Recognition Standards for Medical Homes
TUESDAY, April 8, 2014 (HealthDay News) -- The National Committee for Quality Assurance (NCQA) has updated its guidelines for patient-centered medical homes, according to an article published March 27 in Medical Economics.
Full Article
More Information
USPSTF Recommends Low-Dose Aspirin to Prevent Preeclampsia
MONDAY, April 7, 2014 (HealthDay News) -- The United States Preventive Services Task Force (USPSTF) recommends low-dose aspirin after 12 weeks' gestation for women at high-risk of preeclampsia. This draft recommendation statement is based on an evidence review published online April 8 in the Annals of Internal Medicine.
Evidence Report
Recommendation Statement
Comment on Recommendation
Newly Eligible for Expanded Medicaid Are Healthier
MONDAY, April 7, 2014 (HealthDay News) -- Persons newly eligible for expanded Medicaid coverage under the Affordable Care Act (ACA) are not sicker than pre-ACA enrollees, according to research published online March 26 in Health Affairs.
Abstract
Full Text (subscription or payment may be required)
IL-18 Could Benefit Wet Age-Related Macular Degeneration
MONDAY, April 7, 2014 (HealthDay News) -- The inflammatory cytokine interleukin-18 (IL-18) prevents choroidal neovascularization but does not affect retinal pigment epithelial cell viability, and may be a viable therapeutic option for wet age-related macular degeneration, according to an experimental study published in the April 2 issue of Science Translational Medicine.
Abstract
Full Text (subscription or payment may be required)
Vitamin D Supplementation May Be Beneficial in Depression
MONDAY, April 7, 2014 (HealthDay News) -- Vitamin D supplementation has no overall effect on depressive symptoms, but may have a significant effect for those with clinically significant depression, according to a review published online March 14 in Psychosomatic Medicine.
Abstract
Full Text (subscription or payment may be required)
AMA Provides Resources to Aid Physicians' Collections
FRIDAY, April 4, 2014 (HealthDay News) -- The American Medical Association (AMA) has released resources to help doctors confront policy jumpers who may pose a financial risk to physicians during the Affordable Care Act's 90-day premium grace period, according to an article published March 25 in Medical Economics.
More Information
Transplant Drugs Cut Persistent HIV Levels
THURSDAY, April 3, 2014 (HealthDay News) -- Immunosuppressant therapy taken following kidney transplantation may help reduce persistent HIV burdens in infected patients, according to a study published online April 3 in the American Journal of Transplantation.
Abstract
Full Text (subscription or payment may be required)
Study Examines Fertility Drug Effect on Breast Cancer Risk
THURSDAY, April 3, 2014 (HealthDay News) -- Women with ever use of clomiphene have no increased breast cancer risk, although women undergoing multiple clomiphene cycles have an increased risk of invasive breast cancer, according to a study published online April 3 in Cancer Epidemiology, Biomarkers & Prevention.
Abstract
Full Text
FDA Approves Sublingual Tablet for Grass Allergies
WEDNESDAY, April 2, 2014 (HealthDay News) -- Oralair has been approved by the U.S. Food and Drug Administration as the first sublingual treatment for certain grass allergies.
More Information
Half of Uninsured Don't Intend to Sign Up for Health Coverage
WEDNESDAY, April 2, 2014 (HealthDay News) -- About 50 percent of uninsured adults do not intend to sign up for coverage through the Affordable Care Act's health care exchanges, according to an article published March 26 in Medical Economics.
More Information
Kaiser Family Foundation Poll
Lack of Clear Evidence for Health Benefits of Vitamin D
WEDNESDAY, April 2, 2014 (HealthDay News) -- Evidence is lacking for the associations between vitamin D and health outcomes, according to one review published April 1 in BMJ; however, lower levels of circulating 25-hydroxyvitamin D correlate with increased mortality, according to another review also published April 1 in BMJ.
Full Text - Theodoratou
Full Text - Chowdhury
Editorial
Attention to Postpartum Contraception Needed
WEDNESDAY, April 2, 2014 (HealthDay News) -- Women in the postpartum period should receive counseling and access to contraceptive methods to promote optimal birth spacing, according to research published in the April issue of the American Journal of Obstetrics & Gynecology.
Abstract
Full Text (subscription or payment may be required)
Tadalafil Not Helpful for ED in Prostate CA Post-Radiotherapy
WEDNESDAY, April 2, 2014 (HealthDay News) -- Among men receiving radiotherapy for prostate cancer, daily use of tadalafil is not more effective than placebo in preventing erectile dysfunction, according to research published in the April 2 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
ACEIs, Not ARBs, Reduce Cardiac Mortality in Diabetes
WEDNESDAY, April 2, 2014 (HealthDay News) -- For patients with diabetes mellitus (DM), angiotensin-converting enzyme inhibitors (ACEIs), but not angiotensin II receptor blockers (ARBs), reduce all-cause and cardiovascular (CV) mortality, according to research published online March 31 in JAMA Internal Medicine.
Abstract
Full Text (subscription or payment may be required)
CMS: Medicare Beneficiaries Saved $3.9B on Meds in 2013
TUESDAY, April 1, 2014 (HealthDay News) -- In 2013, 4.3 million seniors and people with disabilities saved an estimated $3.9 billion on prescription drugs, an increase from the 2012 savings, according to a report published by the U.S. Department of Health and Human Services.
More Information
Nearly One-Third of Initial Prescriptions Remain Unfilled
TUESDAY, April 1, 2014 (HealthDay News) -- A sizable number of patients fail to fill their initial drug prescriptions, according to research published in the April 1 issue of the Annals of Internal Medicine.
Full Text (subscription or payment may be required)
